Skip to main content

A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units*.

Publication ,  Journal Article
Marsteller, JA; Sexton, JB; Hsu, Y-J; Hsiao, C-J; Holzmueller, CG; Pronovost, PJ; Thompson, DA
Published in: Crit Care Med
November 2012

OBJECTIVES: To determine the causal effects of an intervention proven effective in pre-post studies in reducing central line-associated bloodstream infections in the intensive care unit. DESIGN: We conducted a multicenter, phased, cluster-randomized controlled trial in which hospitals were randomized into two groups. The intervention group started in March 2007 and the control group started in October 2007; the study period ended September 2008. Baseline data for both groups are from 2006. SETTING: Forty-five intensive care units from 35 hospitals in two Adventist healthcare systems. INTERVENTIONS: A multifaceted intervention involving evidence-based practices to prevent central line-associated bloodstream infections and the Comprehensive Unit-based Safety Program to improve safety, teamwork, and communication. MEASUREMENTS AND RESULTS: We measured central line-associated bloodstream infections per 1,000 central line days and reported quarterly rates. Baseline average central line-associated bloodstream infections per 1,000 central line days was 4.48 and 2.71, for the intervention and control groups (p = .28), respectively. By October to December 2007, the infection rate declined to 1.33 in the intervention group compared to 2.16 in the control group (adjusted incidence rate ratio 0.19; p = .003; 95% confidence interval 0.06-0.57). The intervention group sustained rates <1/1,000 central line days at 19 months (an 81% reduction). The control group also reduced infection rates to <1/1,000 central line days (a 69% reduction) at 12 months. CONCLUSIONS: This study demonstrated a causal relationship between the multifaceted intervention and the reduced central line-associated bloodstream infections. Both groups decreased infection rates after implementation and sustained these results over time, replicating the results found in previous, pre-post studies of this multifaceted intervention and providing further evidence that most central line-associated bloodstream infections are preventable.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Crit Care Med

DOI

EISSN

1530-0293

Publication Date

November 2012

Volume

40

Issue

11

Start / End Page

2933 / 2939

Location

United States

Related Subject Headings

  • United States
  • Quality Improvement
  • Intensive Care Units
  • Humans
  • Evidence-Based Practice
  • Emergency & Critical Care Medicine
  • Cross Infection
  • Cluster Analysis
  • Catheterization, Central Venous
  • Catheter-Related Infections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Marsteller, J. A., Sexton, J. B., Hsu, Y.-J., Hsiao, C.-J., Holzmueller, C. G., Pronovost, P. J., & Thompson, D. A. (2012). A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units*. Crit Care Med, 40(11), 2933–2939. https://doi.org/10.1097/CCM.0b013e31825fd4d8
Marsteller, Jill A., J Bryan Sexton, Yea-Jen Hsu, Chun-Ju Hsiao, Christine G. Holzmueller, Peter J. Pronovost, and David A. Thompson. “A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units*.Crit Care Med 40, no. 11 (November 2012): 2933–39. https://doi.org/10.1097/CCM.0b013e31825fd4d8.
Marsteller JA, Sexton JB, Hsu Y-J, Hsiao C-J, Holzmueller CG, Pronovost PJ, et al. A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units*. Crit Care Med. 2012 Nov;40(11):2933–9.
Marsteller, Jill A., et al. “A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units*.Crit Care Med, vol. 40, no. 11, Nov. 2012, pp. 2933–39. Pubmed, doi:10.1097/CCM.0b013e31825fd4d8.
Marsteller JA, Sexton JB, Hsu Y-J, Hsiao C-J, Holzmueller CG, Pronovost PJ, Thompson DA. A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units*. Crit Care Med. 2012 Nov;40(11):2933–2939.

Published In

Crit Care Med

DOI

EISSN

1530-0293

Publication Date

November 2012

Volume

40

Issue

11

Start / End Page

2933 / 2939

Location

United States

Related Subject Headings

  • United States
  • Quality Improvement
  • Intensive Care Units
  • Humans
  • Evidence-Based Practice
  • Emergency & Critical Care Medicine
  • Cross Infection
  • Cluster Analysis
  • Catheterization, Central Venous
  • Catheter-Related Infections